Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

Publisher： Karger

E-ISSN： 1423-0399|91|4|423-428

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.91, Iss.4, 2013-06, pp. : 423-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Botulinum toxin A for NDO in Japanese SCI

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 306-309

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Portable Device for Experimental Treatment of Neurogenic Detrusor Overactivity

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 158-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Experience with Intradetrusor Injection of Botulinum-A Toxin for the Treatment of Idiopathic Detrusor Overactivity in a Single Irish Institution

By  

Current Urology, Vol. 2, Iss. 2, 2008-11 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

Editorial Comment to Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: Multi‐institutional experience in Japan

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 310-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years

By  

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 379-385

Karger

Access to resources Recommend Favorite